fundvisualizer.com

T. Rowe Price Value ZTRZAX

Performance (before sales charge)

As of 06/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 06/30/2024
Stock
95.28%
Non-U.S. Stock
4.50%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.21%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 06/30/2024

Basic materials

3.76%

Consumer cyclical

4.75%

Financial services

20.37%

Real estate

2.29%

Consumer defensive

9.66%

Health care

17.13%

Utilities

2.63%

Communication services

1.66%

Energy

10.07%

Industrials

16.04%

Technology

10.76%

Top 10 holdings

As of 06/30/2024

Berkshire Hathaway Inc Class B
3.45%
JPMorgan Chase & Co
3.13%
Elevance Health Inc
2.89%
Kenvue Inc
2.43%
Johnson & Johnson
2.29%
Bank of America Corp
2.17%
UnitedHealth Group Inc
2.09%
Fiserv Inc
1.92%
ConocoPhillips
1.79%
Charles Schwab Corp
1.75%
Fund assets

$29.39 Billion

Share class

Inst

Morningstar category

Large Value

Expense ratio

--

Investment objective

Growth

Documents